# AVANDARYL
> **NDA021700** · New Drug Application · Sponsor: SB PHARMCO · Approved 2005-11-23
## Drug
- **FDA Application Number:** NDA021700
- **Application type:** New Drug Application
- **Brand name:** AVANDARYL
- **Generic name:** Glimepiride
- **Active ingredients:** GLIMEPIRIDE; ROSIGLITAZONE MALEATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SB PHARMCO
- **First approval:** 2005-11-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021700)
---
*AI Analytics · CC0 1.0*